{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-009580","form_type":"8-K","ticker":"AIMD","cik":"0001014763","company_name":"Ainos, Inc.","filed_at":"2025-05-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.152238+00:00","generated_at":"2026-05-21T22:41:26.322259+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Ainos Q1 revenue up 412% to $106K; gross profit swings to positive; partnerships in robotics and semiconductors","bullets":["Revenue up 412% YoY to $106,207; gross profit of $87,974 vs prior-year gross loss of $6,025.","Cost of revenue down 32% YoY to $18,233, driving gross margin improvement.","AI Nose deployed in semiconductor manufacturing via ASE partnership; olfactory module installed on ugo robots.","VELDONA secured TFDA approval for HIV oral warts trial and IRB clearance for Sjögren's syndrome trial.","No net income or EPS disclosed; share-based compensation increased SG&A expenses."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-009580","json":"https://secwatch.observer/filing/0001641172-25-009580.json","markdown":"https://secwatch.observer/filing/0001641172-25-009580.md","text":"https://secwatch.observer/filing/0001641172-25-009580.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1014763/000164117225009580/0001641172-25-009580-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1014763/000164117225009580/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T22:41:26.322259+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}